Guinea-Bissau
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
10.82 (9.02 - 12.39) | 2019 | Modelled | IHME |
11.83 (9.67 - 13.59) | 2018 | Modelled | IHME |
12.26 (9.99 - 14.31) | 2017 | Modelled | IHME |
12.09 (9.94 - 14.12) | 2016 | Modelled | IHME |
11.93 (9.81 - 14.04) | 2015 | Modelled | IHME |
12.1 (9.97 - 14.12) | 2014 | Modelled | IHME |
12.51 (10.37 - 14.51) | 2013 | Modelled | IHME |
13.06 (10.88 - 15.13) | 2012 | Modelled | IHME |
13.62 (11.26 - 15.81) | 2011 | Modelled | IHME |
14.07 (11.53 - 16.51) | 2010 | Modelled | IHME |
14.44 (11.81 - 16.80) | 2009 | Modelled | IHME |
14.82 (12.10 - 17.14) | 2008 | Modelled | IHME |
15.17 (12.33 - 17.60) | 2007 | Modelled | IHME |
15.44 (12.55 - 18.08) | 2006 | Modelled | IHME |
15.58 (12.55 - 18.38) | 2005 | Modelled | IHME |
15.64 (12.65 - 18.30) | 2004 | Modelled | IHME |
15.68 (12.70 - 18.28) | 2003 | Modelled | IHME |
15.71 (12.72 - 18.38) | 2002 | Modelled | IHME |
15.74 (12.74 - 18.50) | 2001 | Modelled | IHME |
15.79 (12.79 - 18.58) | 2000 | Modelled | IHME |
15.92 (12.91 - 18.67) | 1999 | Modelled | IHME |
16.13 (13.04 - 18.85) | 1998 | Modelled | IHME |
16.36 (13.17 - 19.11) | 1997 | Modelled | IHME |
16.56 (13.28 - 19.42) | 1996 | Modelled | IHME |
16.66 (13.25 - 19.67) | 1995 | Modelled | IHME |
16.69 (13.40 - 19.72) | 1994 | Modelled | IHME |
16.71 (13.40 - 19.81) | 1993 | Modelled | IHME |
16.73 (13.45 - 19.90) | 1992 | Modelled | IHME |
16.74 (13.47 - 19.96) | 1991 | Modelled | IHME |
16.73 (13.43 - 20.09) | 1990 | Modelled | IHME |
5.11 (0.41 - 38.31) | 2015 | Modelled | WHO |
Showing out of
Show more
Children under-5 years
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
3.77 (2.78 - 4.70) | 2019 | Modelled | IHME |
3.98 (2.92 - 5.02) | 2018 | Modelled | IHME |
4.02 (2.85 - 5.22) | 2017 | Modelled | IHME |
3.75 (2.71 - 4.80) | 2016 | Modelled | IHME |
3.46 (2.55 - 4.47) | 2015 | Modelled | IHME |
3.43 (2.50 - 4.39) | 2014 | Modelled | IHME |
3.4 (2.50 - 4.30) | 2013 | Modelled | IHME |
3.39 (2.47 - 4.27) | 2012 | Modelled | IHME |
3.38 (2.46 - 4.25) | 2011 | Modelled | IHME |
3.37 (2.44 - 4.27) | 2010 | Modelled | IHME |
4.32 (3.14 - 5.42) | 2009 | Modelled | IHME |
6.6 (4.78 - 8.22) | 2008 | Modelled | IHME |
9.32 (6.77 - 11.57) | 2007 | Modelled | IHME |
11.62 (8.39 - 14.58) | 2006 | Modelled | IHME |
12.62 (8.98 - 16.21) | 2005 | Modelled | IHME |
12.68 (9.02 - 16.21) | 2004 | Modelled | IHME |
12.71 (9.02 - 16.27) | 2003 | Modelled | IHME |
12.73 (9.02 - 16.43) | 2002 | Modelled | IHME |
12.75 (9.04 - 16.61) | 2001 | Modelled | IHME |
12.79 (8.96 - 16.84) | 2000 | Modelled | IHME |
12.89 (9.01 - 16.82) | 1999 | Modelled | IHME |
13.06 (9.18 - 16.84) | 1998 | Modelled | IHME |
13.27 (9.38 - 16.91) | 1997 | Modelled | IHME |
13.44 (9.52 - 17.07) | 1996 | Modelled | IHME |
13.54 (9.55 - 17.34) | 1995 | Modelled | IHME |
13.59 (9.66 - 17.28) | 1994 | Modelled | IHME |
13.63 (9.69 - 17.23) | 1993 | Modelled | IHME |
13.67 (9.73 - 17.44) | 1992 | Modelled | IHME |
13.7 (9.73 - 17.45) | 1991 | Modelled | IHME |
13.72 (9.67 - 17.69) | 1990 | Modelled | IHME |
2.12 (0.18 - 20.45) | 2015 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
168,532 (135,269 - 202,327) | 1990 | Modelled | IHME |
172,413 (138,783 - 205,661) | 1991 | Modelled | IHME |
176,234 (141,673 - 209,593) | 1992 | Modelled | IHME |
180,007 (144,290 - 213,378) | 1993 | Modelled | IHME |
183,737 (147,541 - 217,091) | 1994 | Modelled | IHME |
187,460 (149,097 - 221,321) | 1995 | Modelled | IHME |
190,369 (152,721 - 223,200) | 1996 | Modelled | IHME |
192,106 (154,600 - 224,324) | 1997 | Modelled | IHME |
193,381 (156,266 - 225,981) | 1998 | Modelled | IHME |
194,861 (157,971 - 228,435) | 1999 | Modelled | IHME |
197,409 (159,857 - 232,230) | 2000 | Modelled | IHME |
201,016 (162,684 - 236,200) | 2001 | Modelled | IHME |
204,934 (165,998 - 239,755) | 2002 | Modelled | IHME |
209,011 (169,299 - 243,632) | 2003 | Modelled | IHME |
213,080 (172,342 - 249,256) | 2004 | Modelled | IHME |
216,938 (174,745 - 255,839) | 2005 | Modelled | IHME |
219,631 (178,599 - 257,282) | 2006 | Modelled | IHME |
220,666 (179,379 - 256,094) | 2007 | Modelled | IHME |
220,535 (180,118 - 255,127) | 2008 | Modelled | IHME |
219,810 (179,721 - 255,802) | 2009 | Modelled | IHME |
219,124 (179,555 - 257,223) | 2010 | Modelled | IHME |
217,097 (179,558 - 252,081) | 2011 | Modelled | IHME |
213,059 (177,401 - 246,763) | 2012 | Modelled | IHME |
208,855 (173,044 - 242,122) | 2013 | Modelled | IHME |
206,511 (170,237 - 241,042) | 2014 | Modelled | IHME |
208,250 (171,226 - 245,001) | 2015 | Modelled | IHME |
215,740 (177,354 - 251,821) | 2016 | Modelled | IHME |
223,371 (182,077 - 260,821) | 2017 | Modelled | IHME |
220,153 (179,972 - 252,977) | 2018 | Modelled | IHME |
205,691 (171,559 - 235,644) | 2019 | Modelled | IHME |
Showing out of
Show more
HBV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
12.7 (9.05 - 17.40) | 2019 | Modelled | IHME |
14 (10.20 - 19.10) | 2018 | Modelled | IHME |
14.8 (10.80 - 19.70) | 2017 | Modelled | IHME |
14.9 (10.90 - 19.90) | 2016 | Modelled | IHME |
14.9 (10.90 - 19.80) | 2015 | Modelled | IHME |
14.9 (10.90 - 20) | 2014 | Modelled | IHME |
14.9 (11 - 20.10) | 2013 | Modelled | IHME |
14.9 (11 - 19.90) | 2012 | Modelled | IHME |
15 (11.10 - 20) | 2011 | Modelled | IHME |
15.1 (11.10 - 20.20) | 2010 | Modelled | IHME |
15.4 (11.40 - 20.50) | 2009 | Modelled | IHME |
16 (11.90 - 21.40) | 2008 | Modelled | IHME |
16.9 (12.40 - 22.50) | 2007 | Modelled | IHME |
17.5 (12.60 - 23) | 2006 | Modelled | IHME |
18 (12.60 - 24) | 2005 | Modelled | IHME |
18.1 (12.60 - 24.50) | 2004 | Modelled | IHME |
17.8 (12.50 - 24.10) | 2003 | Modelled | IHME |
17.5 (12.34 - 23.60) | 2002 | Modelled | IHME |
17.2 (12.30 - 23.30) | 2001 | Modelled | IHME |
16.8 (12.30 - 23.10) | 2000 | Modelled | IHME |
16.9 (12.30 - 22.90) | 1999 | Modelled | IHME |
17.2 (12.50 - 23.40) | 1998 | Modelled | IHME |
17.5 (12.60 - 23.80) | 1997 | Modelled | IHME |
17.8 (12.80 - 24.60) | 1996 | Modelled | IHME |
18.1 (12.90 - 25.10) | 1995 | Modelled | IHME |
18.3 (13 - 25.50) | 1994 | Modelled | IHME |
18.6 (13.20 - 25.70) | 1993 | Modelled | IHME |
18.8 (13.30 - 26) | 1992 | Modelled | IHME |
19.1 (13.30 - 26.50) | 1991 | Modelled | IHME |
19.3 (13.30 - 27) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
241 (172 - 331) | 2019 | Modelled | IHME |
261 (190 - 355) | 2018 | Modelled | IHME |
270 (197 - 359) | 2017 | Modelled | IHME |
265 (194 - 355) | 2016 | Modelled | IHME |
260 (191 - 346) | 2015 | Modelled | IHME |
255 (187 - 342) | 2014 | Modelled | IHME |
249 (184 - 336) | 2013 | Modelled | IHME |
243 (179 - 325) | 2012 | Modelled | IHME |
239 (176 - 319) | 2011 | Modelled | IHME |
235 (172 - 314) | 2010 | Modelled | IHME |
234 (174 - 313) | 2009 | Modelled | IHME |
238 (177 - 318) | 2008 | Modelled | IHME |
246 (180 - 327) | 2007 | Modelled | IHME |
249 (179 - 328) | 2006 | Modelled | IHME |
251 (175 - 334) | 2005 | Modelled | IHME |
247 (171 - 333) | 2004 | Modelled | IHME |
237 (166 - 322) | 2003 | Modelled | IHME |
228 (161 - 308) | 2002 | Modelled | IHME |
219 (157 - 298) | 2001 | Modelled | IHME |
210 (154 - 288) | 2000 | Modelled | IHME |
206 (151 - 280) | 1999 | Modelled | IHME |
206 (149 - 281) | 1998 | Modelled | IHME |
205 (148 - 280) | 1997 | Modelled | IHME |
205 (147 - 282) | 1996 | Modelled | IHME |
204 (145 - 282) | 1995 | Modelled | IHME |
202 (143 - 281) | 1994 | Modelled | IHME |
200 (142 - 277) | 1993 | Modelled | IHME |
198 (140 - 274) | 1992 | Modelled | IHME |
196 (137 - 273) | 1991 | Modelled | IHME |
195 (134 - 272) | 1990 | Modelled | IHME |
223 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
51 (42 - 60) | 2019 | Modelled | IHME |
52 (44 - 61) | 2018 | Modelled | IHME |
52 (44 - 61) | 2017 | Modelled | IHME |
52 (44 - 61) | 2016 | Modelled | IHME |
52 (44 - 61) | 2015 | Modelled | IHME |
52 (44 - 61) | 2014 | Modelled | IHME |
52 (43 - 61) | 2013 | Modelled | IHME |
52 (43 - 61) | 2012 | Modelled | IHME |
52 (43 - 61) | 2011 | Modelled | IHME |
52 (43 - 61) | 2010 | Modelled | IHME |
52 (43 - 61) | 2009 | Modelled | IHME |
52 (44 - 61) | 2008 | Modelled | IHME |
53 (44 - 61) | 2007 | Modelled | IHME |
53 (45 - 61) | 2006 | Modelled | IHME |
53 (45 - 62) | 2005 | Modelled | IHME |
53 (45 - 62) | 2004 | Modelled | IHME |
53 (44 - 62) | 2003 | Modelled | IHME |
53 (44 - 62) | 2002 | Modelled | IHME |
53 (44 - 62) | 2001 | Modelled | IHME |
53 (45 - 62) | 2000 | Modelled | IHME |
53 (45 - 62) | 1999 | Modelled | IHME |
53 (45 - 62) | 1998 | Modelled | IHME |
53 (45 - 62) | 1997 | Modelled | IHME |
53 (45 - 62) | 1996 | Modelled | IHME |
53 (45 - 62) | 1995 | Modelled | IHME |
53 (45 - 62) | 1994 | Modelled | IHME |
53 (45 - 62) | 1993 | Modelled | IHME |
53 (45 - 62) | 1992 | Modelled | IHME |
53 (44 - 63) | 1991 | Modelled | IHME |
53 (44 - 62) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
88 | 2018 | Survey/reported | WHO/UNICEF |
88 | 2017 | Survey/reported | WHO/UNICEF |
88 | 2016 | Survey/reported | WHO/UNICEF |
88 | 2015 | Survey/reported | WHO/UNICEF |
88 | 2014 | Survey/reported | WHO/UNICEF |
87 | 2013 | Survey/reported | WHO/UNICEF |
87 | 2012 | Survey/reported | WHO/UNICEF |
89 | 2011 | Survey/reported | WHO/UNICEF |
82 | 2010 | Survey/reported | WHO/UNICEF |
80 | 2009 | Survey/reported | WHO/UNICEF |
84 | 2019 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
2.02 (1.62 - 2.53) | 2019 | Modelled | IHME |
2.02 (1.61 - 2.57) | 2018 | Modelled | IHME |
2.03 (1.61 - 2.58) | 2017 | Modelled | IHME |
2.05 (1.65 - 2.56) | 2016 | Modelled | IHME |
2.06 (1.67 - 2.56) | 2015 | Modelled | IHME |
2.05 (1.66 - 2.54) | 2014 | Modelled | IHME |
2.03 (1.64 - 2.51) | 2013 | Modelled | IHME |
2 (1.60 - 2.48) | 2012 | Modelled | IHME |
1.97 (1.58 - 2.46) | 2011 | Modelled | IHME |
1.96 (1.56 - 2.44) | 2010 | Modelled | IHME |
1.97 (1.57 - 2.45) | 2009 | Modelled | IHME |
1.99 (1.58 - 2.48) | 2008 | Modelled | IHME |
2.01 (1.60 - 2.52) | 2007 | Modelled | IHME |
2.04 (1.63 - 2.57) | 2006 | Modelled | IHME |
2.06 (1.65 - 2.59) | 2005 | Modelled | IHME |
2.08 (1.66 - 2.60) | 2004 | Modelled | IHME |
2.1 (1.68 - 2.61) | 2003 | Modelled | IHME |
2.11 (1.70 - 2.63) | 2002 | Modelled | IHME |
2.13 (1.71 - 2.65) | 2001 | Modelled | IHME |
2.15 (1.74 - 2.67) | 2000 | Modelled | IHME |
2.2 (1.78 - 2.73) | 1999 | Modelled | IHME |
2.27 (1.83 - 2.82) | 1998 | Modelled | IHME |
2.34 (1.88 - 2.92) | 1997 | Modelled | IHME |
2.42 (1.93 - 3.03) | 1996 | Modelled | IHME |
2.46 (1.97 - 3.09) | 1995 | Modelled | IHME |
2.5 (2 - 3.13) | 1994 | Modelled | IHME |
2.52 (2.04 - 3.17) | 1993 | Modelled | IHME |
2.55 (2.05 - 3.20) | 1992 | Modelled | IHME |
2.56 (2.07 - 3.23) | 1991 | Modelled | IHME |
2.57 (2.07 - 3.24) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of people living with chronic HCV (RNA+/cAg)
National
DownloadValue | Year | Type | Source |
---|---|---|---|
25,908 (20,883 - 32,640) | 1990 | Modelled | IHME |
26,419 (21,311 - 33,313) | 1991 | Modelled | IHME |
26,840 (21,642 - 33,747) | 1992 | Modelled | IHME |
27,187 (21,934 - 34,106) | 1993 | Modelled | IHME |
27,475 (22,049 - 34,482) | 1994 | Modelled | IHME |
27,728 (22,162 - 34,753) | 1995 | Modelled | IHME |
27,768 (22,187 - 34,850) | 1996 | Modelled | IHME |
27,519 (22,115 - 34,298) | 1997 | Modelled | IHME |
27,163 (21,916 - 33,813) | 1998 | Modelled | IHME |
26,882 (21,741 - 33,425) | 1999 | Modelled | IHME |
26,892 (21,723 - 33,421) | 2000 | Modelled | IHME |
27,173 (21,859 - 33,870) | 2001 | Modelled | IHME |
27,530 (22,116 - 34,355) | 2002 | Modelled | IHME |
27,931 (22,388 - 34,824) | 2003 | Modelled | IHME |
28,343 (22,653 - 35,462) | 2004 | Modelled | IHME |
28,728 (22,909 - 36,000) | 2005 | Modelled | IHME |
29,034 (23,146 - 36,535) | 2006 | Modelled | IHME |
29,285 (23,348 - 36,681) | 2007 | Modelled | IHME |
29,556 (23,552 - 36,945) | 2008 | Modelled | IHME |
29,931 (23,897 - 37,305) | 2009 | Modelled | IHME |
30,504 (24,377 - 38,073) | 2010 | Modelled | IHME |
31,392 (25,206 - 39,138) | 2011 | Modelled | IHME |
32,553 (26,174 - 40,494) | 2012 | Modelled | IHME |
33,831 (27,317 - 41,878) | 2013 | Modelled | IHME |
35,055 (28,393 - 43,426) | 2014 | Modelled | IHME |
36,038 (29,213 - 44,678) | 2015 | Modelled | IHME |
36,535 (29,367 - 45,752) | 2016 | Modelled | IHME |
36,956 (29,431 - 47,105) | 2017 | Modelled | IHME |
37,623 (30,022 - 47,800) | 2018 | Modelled | IHME |
38,347 (30,732 - 48,091) | 2019 | Modelled | IHME |
Showing out of
Show more
HCV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
2 (1.31 - 2.95) | 2019 | Modelled | IHME |
1.87 (1.24 - 2.73) | 2018 | Modelled | IHME |
1.84 (1.22 - 2.65) | 2017 | Modelled | IHME |
1.84 (1.22 - 2.66) | 2016 | Modelled | IHME |
1.83 (1.23 - 2.61) | 2015 | Modelled | IHME |
1.86 (1.24 - 2.67) | 2014 | Modelled | IHME |
1.89 (1.26 - 2.73) | 2013 | Modelled | IHME |
1.93 (1.30 - 2.82) | 2012 | Modelled | IHME |
1.98 (1.33 - 2.87) | 2011 | Modelled | IHME |
2.01 (1.34 - 2.90) | 2010 | Modelled | IHME |
2.02 (1.35 - 2.94) | 2009 | Modelled | IHME |
2.03 (1.36 - 2.96) | 2008 | Modelled | IHME |
2.05 (1.36 - 3.01) | 2007 | Modelled | IHME |
2.04 (1.35 - 3.01) | 2006 | Modelled | IHME |
2.04 (1.35 - 2.97) | 2005 | Modelled | IHME |
2.07 (1.35 - 3.02) | 2004 | Modelled | IHME |
2.05 (1.34 - 3.01) | 2003 | Modelled | IHME |
2.05 (1.35 - 3.04) | 2002 | Modelled | IHME |
2.05 (1.33 - 3.01) | 2001 | Modelled | IHME |
2.05 (1.33 - 3.02) | 2000 | Modelled | IHME |
2.08 (1.33 - 3.06) | 1999 | Modelled | IHME |
2.12 (1.36 - 3.12) | 1998 | Modelled | IHME |
2.16 (1.38 - 3.18) | 1997 | Modelled | IHME |
2.2 (1.39 - 3.25) | 1996 | Modelled | IHME |
2.23 (1.41 - 3.31) | 1995 | Modelled | IHME |
2.26 (1.43 - 3.38) | 1994 | Modelled | IHME |
2.3 (1.42 - 3.48) | 1993 | Modelled | IHME |
2.34 (1.44 - 3.58) | 1992 | Modelled | IHME |
2.37 (1.48 - 3.66) | 1991 | Modelled | IHME |
2.42 (1.48 - 3.72) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
38 (25 - 56) | 2019 | Modelled | IHME |
35 (23 - 51) | 2018 | Modelled | IHME |
34 (22 - 48) | 2017 | Modelled | IHME |
33 (22 - 47) | 2016 | Modelled | IHME |
32 (21 - 45) | 2015 | Modelled | IHME |
32 (21 - 46) | 2014 | Modelled | IHME |
32 (21 - 46) | 2013 | Modelled | IHME |
32 (21 - 46) | 2012 | Modelled | IHME |
31 (21 - 46) | 2011 | Modelled | IHME |
31 (21 - 45) | 2010 | Modelled | IHME |
31 (21 - 45) | 2009 | Modelled | IHME |
30 (20 - 44) | 2008 | Modelled | IHME |
30 (20 - 44) | 2007 | Modelled | IHME |
29 (19 - 43) | 2006 | Modelled | IHME |
28 (19 - 41) | 2005 | Modelled | IHME |
28 (18 - 41) | 2004 | Modelled | IHME |
27 (18 - 40) | 2003 | Modelled | IHME |
27 (18 - 40) | 2002 | Modelled | IHME |
26 (17 - 38) | 2001 | Modelled | IHME |
26 (17 - 38) | 2000 | Modelled | IHME |
25 (16 - 37) | 1999 | Modelled | IHME |
25 (16 - 37) | 1998 | Modelled | IHME |
25 (16 - 37) | 1997 | Modelled | IHME |
25 (16 - 37) | 1996 | Modelled | IHME |
25 (16 - 37) | 1995 | Modelled | IHME |
25 (16 - 37) | 1994 | Modelled | IHME |
25 (15 - 38) | 1993 | Modelled | IHME |
25 (15 - 38) | 1992 | Modelled | IHME |
24 (15 - 38) | 1991 | Modelled | IHME |
24 (15 - 37) | 1990 | Modelled | IHME |
63 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
17 (12 - 23) | 2019 | Modelled | IHME |
17 (11 - 23) | 2018 | Modelled | IHME |
16 (11 - 23) | 2017 | Modelled | IHME |
16 (11 - 23) | 2016 | Modelled | IHME |
17 (11 - 22) | 2015 | Modelled | IHME |
17 (11 - 23) | 2014 | Modelled | IHME |
17 (11 - 22) | 2013 | Modelled | IHME |
17 (12 - 23) | 2012 | Modelled | IHME |
17 (11 - 22) | 2011 | Modelled | IHME |
17 (11 - 23) | 2010 | Modelled | IHME |
17 (11 - 22) | 2009 | Modelled | IHME |
17 (11 - 22) | 2008 | Modelled | IHME |
16 (11 - 22) | 2007 | Modelled | IHME |
16 (11 - 22) | 2006 | Modelled | IHME |
16 (11 - 22) | 2005 | Modelled | IHME |
16 (11 - 22) | 2004 | Modelled | IHME |
16 (11 - 22) | 2003 | Modelled | IHME |
16 (11 - 22) | 2002 | Modelled | IHME |
16 (11 - 22) | 2001 | Modelled | IHME |
16 (11 - 22) | 2000 | Modelled | IHME |
16 (11 - 22) | 1999 | Modelled | IHME |
16 (11 - 22) | 1998 | Modelled | IHME |
16 (11 - 22) | 1997 | Modelled | IHME |
16 (11 - 22) | 1996 | Modelled | IHME |
16 (11 - 22) | 1995 | Modelled | IHME |
16 (11 - 22) | 1994 | Modelled | IHME |
16 (11 - 22) | 1993 | Modelled | IHME |
16 (11 - 22) | 1992 | Modelled | IHME |
16 (11 - 22) | 1991 | Modelled | IHME |
16 (11 - 22) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Prevalence < 5
HBV
3.77
(%)
2019, latest modelled
(2.78 - 4.70(%))
IHME
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
No. of syringes/PWID/year
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines